KTKenric Tam

Kenric Tam

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kenric Tam has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • TPC-based neoadjuvant chemotherapy is associated with reduced surgical morbidity with no detriment on survival in a propensity-matched cohort of locally advanced OCSCC

    by Kenric Tam, Giovanna Caxeiro, Lara Dunn, Lillian A. Boe, Emma Finnegan, Eric Sherman, Bin Xu, Ronald Ghossein, Marc A. Cohen, Jennifer R. Cracchiolo, et al.

  • Characterization of response-adapted surgery following neoadjuvant systemic therapy in oral cavity cancer

    by Richard J. Lu, Lara Dunn, Kenric Tam, Michael T. Starc, Richard J. Wong, Ian Ganly, Snehal Patel, Nancy Lee, Winston Wong, Marc A. Cohen, et al.


  • Contemporary Surgical Approaches in Managing Laryngeal Chondrosarcoma: A Scoping Review

    by D. Alexander Cronkite, Clare Moffatt, Kenric Tam, Alice C. Yu, Dinesh K. Chhetri, Maie St. John

    Objective: The aim of this scoping review is to describe and evaluate current surgical management options for chondrosarcoma of the larynx, and to summarize these techniques with respect to the laryngeal subsite affected. Data Sources: PubMed/MEDLINE and EMBASE databases. Review Methods: The review was conducted according to the Preferred Reporting Items for Systematic Reviews extension for Scoping Reviews. Results: Forty‐one articles met eligibility criteria for inclusion in the final analysis, which included a total of 149 unique surgical cases that were analyzed based on affected laryngeal subsites of cricoid, thyroid, arytenoid, and epiglottis. Management of cricoid chondrosarcoma favored transoral endoscopic resection (TER) or transcervical laryngeal preservation surgery (TPLS), which ranged from limited tumor debulking via laryngofissure to larger operations like subtotal to total cricoidectomy with laryngeal reconstruction. Nearly all cases of arytenoid and epiglottic chondrosarcoma were successfully managed with TER techniques. Thyroid chondrosarcoma primarily affected the outer cortex of the cartilage and very rarely involved the endolaryngeal mucosa, making it very amenable to transcervical approaches to remove part of or the entire affected thyroid lamina. Conclusion: Overall trends in the articles reviewed for this study suggest that more aggressive surgery and R0 resection did not lead to better overall survival, which aligns with the broader philosophical shift in treatment goals to prioritize preservation of the larynx and laryngeal function over complete oncologic resection. Level of Evidence: NA.


  • Open Access

    Management of Cutaneous Head and Neck Squamous and Basal Cell Carcinomas for Immunocompromised Patients

    by Krishna K. Bommakanti, Nikitha Kosaraju, Kenric Tam, Wanxing Chai-Ho, Maie St. John

    The incidence of non-melanoma skin cancer (NMSC) continues to rise, and more than one million cases are diagnosed in the United States each year. The increase in prevalence has been attributed to increased lifespan and improvements in survival for conditions that increase the risk of these malignancies. Patients who are immunocompromised have a higher risk of developing NMSC compared to the general population. In immunosuppressed patients, a combination of prevention, frequent surveillance, and early intervention are necessary to reduce morbidity and mortality. In this review, we collate and summarize current knowledge regarding pathogenesis of head and neck cutaneous SCC and BCC within immunocompromised patients, examine the potential role of the immune response in disease progression, and detail the role of novel immunotherapies in this subset of patients.


  • Lam Qua and Peter Parker: Portraiture of Head and Neck Surgery in 19th‐Century China

    by Kenric Tam, Jamie A. Kwan

    In 1835, Peter Parker, an American surgeon and Presbyterian minister, established a hospital in Guangzhou and became the first Western head and neck surgeon in China. While Parker documented his most interesting cases in his journals, he also commissioned oil paintings of these patients from Lam Qua (), a prominent Chinese artist trained in British academic painting. Lam Qua produced 86 portraits of Dr Parker's patients, providing insight into not only the treatment of head and neck tumors but also the introduction of Western artistic techniques to 19th‐century China. Parker's pioneering surgical accomplishments and Lam Qua's portraits document the role of art and medicine in America's cultural influence in Asia.


  • Surgical Management of Supraglottic Stenosis Using Intubationless Optiflow

    by Kenric Tam, Caroline Jeffery, C. Kwang Sung

    Objective: Airway management during endoscopic surgical treatment of supraglottic and pharyngeal stenosis is often challenging and can be accomplished by various means, including tracheostomy, jet ventilation, or direct laryngoscopy. We describe CO 2 laser excision of supraglottic-pharyngeal stenosis using intubationless Optiflow high-flow nasal cannula (HFNC). Methods: A 55-year-old male presented with dyspnea and dysphagia secondary to severe supraglottic-pharyngeal stenosis in the setting of previous chemoradiation for a T0N2aM0 squamous cell carcinoma. Laryngoscopy revealed severe supraglottic-pharyngeal stenosis with tethering of the epiglottis to the lateral pharyngeal walls. Optiflow HFNC was used to deliver 70 L/min of oxygen. After anesthetic induction, CO 2 laser microlaryngoscopy was utilized to release scar tissue along the lateral epiglottic border, opening up the supraglottic airway sufficiently for endotracheal intubation and further laser resection. Results: Airway management with Optiflow HFNC allowed initial endoscopic surgical access, partial stenotic release, and intubation. From anesthetic induction to intubation, the patient remained apneic for 26 minutes. The patient’s stenosis was successfully addressed, and 10-month follow-up demonstrated stable patency of the airway. Conclusion: Optiflow is an important new tool in the management of severe supraglottic stenosis. It provides sufficient oxygenation to perform extended apneic surgery and improves endoscopic surgical access in a limited airway.